advertisement

Topcon

Wu X 10

Showing records 1 to 10 | Display all abstracts from Wu X

105053 Outcomes of chronic angle-closure glaucoma treated by phacoemulsification and endocyclophotocoagulation with or without endoscopically goniosynechialysis
Wu X
International Journal of Ophthalmology 2022; 15: 1273-1278
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Li F
Translational vision science & technology 2022; 11: 22
105053 Outcomes of chronic angle-closure glaucoma treated by phacoemulsification and endocyclophotocoagulation with or without endoscopically goniosynechialysis
Wang Y
International Journal of Ophthalmology 2022; 15: 1273-1278
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Pan J
Translational vision science & technology 2022; 11: 22
105053 Outcomes of chronic angle-closure glaucoma treated by phacoemulsification and endocyclophotocoagulation with or without endoscopically goniosynechialysis
Liu X
International Journal of Ophthalmology 2022; 15: 1273-1278
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Yang D; Wu J
Translational vision science & technology 2022; 11: 22
105053 Outcomes of chronic angle-closure glaucoma treated by phacoemulsification and endocyclophotocoagulation with or without endoscopically goniosynechialysis
Li ZH; Deng LQ
International Journal of Ophthalmology 2022; 15: 1273-1278
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Ou Y; Li H
Translational vision science & technology 2022; 11: 22
105053 Outcomes of chronic angle-closure glaucoma treated by phacoemulsification and endocyclophotocoagulation with or without endoscopically goniosynechialysis
Chen DS; Wang DJ
International Journal of Ophthalmology 2022; 15: 1273-1278
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Huang J; Xie H; Ou D; Wu X; Wu B; Sun Q; Fang H; Yang Y; Xu Y; Luo Y; Zhang X
Translational vision science & technology 2022; 11: 22

Issue 23-2

Change Issue


advertisement

Oculus